Arcus Biosciences, Inc. (RCUS)
Arcus Biosciences Market Cap : 1.993B for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.993B |
| November 19, 2026 | 2.014B |
| November 18, 2026 | 2.011B |
| November 17, 2026 | 2.091B |
| November 16, 2026 | 2.151B |
| November 13, 2026 | 2.224B |
| November 12, 2026 | 2.267B |
| November 11, 2026 | 2.399B |
| November 10, 2026 | 2.382B |
| November 09, 2026 | 2.418B |
| November 06, 2026 | 2.333B |
| November 05, 2026 | 2.257B |
| November 04, 2026 | 2.464B |
| November 03, 2026 | 2.413B |
| November 02, 2026 | 2.278B |
| October 30, 2026 | 2.310B |
| October 29, 2026 | 2.363B |
| October 28, 2026 | 2.336B |
| October 27, 2026 | 2.304B |
| October 26, 2026 | 2.256B |
| October 23, 2026 | 2.355B |
| October 22, 2026 | 2.459B |
| October 21, 2026 | 2.426B |
| October 20, 2026 | 3.016B |
| October 19, 2026 | 2.812B |
| Date | Value |
|---|---|
| October 16, 2026 | 2.809B |
| October 15, 2026 | 2.898B |
| October 14, 2026 | 2.861B |
| October 13, 2026 | 2.859B |
| October 12, 2026 | 3.091B |
| October 09, 2026 | 3.100B |
| October 08, 2026 | 3.026B |
| October 07, 2026 | 3.114B |
| October 06, 2026 | 3.084B |
| October 05, 2026 | 3.142B |
| October 02, 2026 | 3.104B |
| October 01, 2026 | 3.204B |
| September 30, 2026 | 3.280B |
| September 29, 2026 | 3.258B |
| September 28, 2026 | 3.176B |
| September 25, 2026 | 3.171B |
| September 24, 2026 | 3.183B |
| September 23, 2026 | 3.352B |
| September 22, 2026 | 3.412B |
| September 21, 2026 | 3.296B |
| September 18, 2026 | 3.205B |
| September 17, 2026 | 3.244B |
| September 16, 2026 | 3.131B |
| September 15, 2026 | 3.089B |
| September 14, 2026 | 3.057B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Halozyme Therapeutics, Inc. | 10.41B |
| AVITA Medical, Inc. | 483.63M |
| Iovance Biotherapeutics, Inc. | 3.192B |
| Editas Medicine, Inc. | 252.00M |
| Recursion Pharmaceuticals, Inc. | 1.375B |
Market Cap Related Metrics
| PS Ratio | 19.42 |
| PEG Ratio | -0.6988 |
| Price to Book Value | 5.567 |
| Price | 15.62 |
| Earnings Yield | -23.31% |
| PEGY Ratio | -0.6988 |